health new england glp 1 coverage Medicaid fuels US of Novo, Lilly weight-loss drugs GIC Non-Medicare Health Plans

Secher, Jelsing, Baqueror)

With key GLP-1 drug patents expected to expire around March 2026, Indian pharmaceutical companies are preparing to launch lower-cost alternatives in one of the fastest-growing therapeutic markets

While GLP-1 receptor agonists, like semaglutide (found in medications such as Wegovy and Ozempic), are associated with weight loss, individual responses can vary greatly

GLP-1

doi: 10.1053/j.gastro.2007.03.054 7 HolstJJKnopFKVilsbllTKrarupTMadsbadS

With the nod, Eohilia becomes the first the first oral treatment for EoE, a chronic allergic condition of the esophagus, according to Takedas announcement